RCKT
Rocket Pharmaceuticals Inc
2.70$
-10.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 74.6% | 66.8% | 69.1% | 65.6% | 61.4% | 71.7% | 68.9% | 65.8% | 61.9% | 58.3% | 52.5% | 68.4% | |
| 37.7% | 9.9% | 7.1% | 8.6% | 16.7% | 31.0% | 10.6% | 7.8% | 20.6% | 23.5% | 17.4% | 53.1% | |
| 73.0% | 65.9% | 66.1% | 62.5% | 59.9% | 70.6% | 67.5% | 64.5% | 60.5% | 57.2% | 50.6% | 67.1% | |
| – | – | 1.7% | 1.8% | – | – | – | – | – | – | – | – | |
| 6.5% | 6.9% | 7.8% | 8.8% | 9.9% | 7.4% | 8.3% | 9.3% | 10.6% | 11.8% | 13.7% | 9.3% | |
| 4.2% | 4.4% | 5.0% | 5.6% | 6.4% | 4.8% | 5.3% | 6.0% | 6.8% | 7.6% | 8.8% | 5.9% | |
| 9.6% | 13.0% | 11.6% | 13.8% | 16.2% | 12.2% | 12.5% | 15.9% | 14.8% | 16.1% | 16.6% | 12.8% | |
| 5.6% | 8.6% | 6.6% | 8.4% | 10.2% | 7.7% | 7.5% | 10.3% | 8.5% | 9.1% | 8.6% | 7.4% | |
| 0.5% | 0.5% | 0.6% | 0.6% | 0.7% | 0.5% | 0.6% | 0.7% | 0.8% | 0.9% | 1.0% | 0.7% | |
| 0.3% | 0.0% | 0.6% | 0.7% | 0.7% | 0.3% | 0.6% | 0.4% | 0.7% | – | 1.5% | 6.7% | |
| 90.4% | 87.0% | 88.4% | 86.2% | 83.8% | 87.8% | 87.5% | 84.1% | 85.2% | 83.9% | 83.4% | 87.2% | |
| -150.3% | -169.4% | -204.5% | -244.4% | -294.1% | -230.8% | -271.6% | -320.3% | -380.0% | -436.1% | -521.7% | -322.8% | |
| 13.8% | 14.8% | 18.7% | 21.0% | 23.9% | 18.5% | 23.4% | 26.4% | 30.3% | 33.6% | 39.3% | 27.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.